This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/23/2023
Location: San Francisco, CA
Subject: Transcatheter Cardiovascular Therapeutics (TCT) 2023 Conference; Fireside Chat
FDA Participant/Group: ANDREW FARB; MICHELLE TARVER; BRAM ZUCKERMAN;
Non FDA Participant/Group: Industry, government, academia, and media

Event Date: 10/23/2023
Location: San Francisco, CA
Subject: Produce Safety
FDA Participant/Group: MICHAEL DUTCHER; JAMES GORNY; JAMES JONES;
Non FDA Participant/Group: Karen Ross, Natalie Krout-Greenberg (California Department of Food and Agriculture);

Event Date: 10/24/2023
Location: San Francisco, CA
Subject: Misinformation and Tobacco
FDA Participant/Group: NICHOLAS ALEXANDER;
Non FDA Participant/Group: Erica Pan, Gordon Sloss, Maral Farsi, Rita Nguyen, Tomas Aragon (California Department of Public Health);

Event Date: 10/25/2023
Location: San Francisco, CA
Subject: Port Operations and Customs and Border Protection Tour
FDA Participant/Group: CINDY LEWIS; MARISSA CHAN; DANIEL SOLIS; JESSICA LEE; KATHLEEN TURNER;
Non FDA Participant/Group: Jeffrey Meleg (Customs and Border Protection);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/23/2023
Location: Salinas, CA
Subject: Produce Field Tour and Meetings with Industry on Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the California Department of Food and Agriculture, Arizona Department of Agriculture, trade associations, and academia

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Acting Associate Commissioner for Regulatory Affairs

Event Date: 10/25/2023
Location: Baltimore, MD
Subject: Association of Food and Drug Officials Fall Board Meeting
FDA Participant/Group: DONALD PRATER; ERIK METTLER;
Non FDA Participant/Group: Board members of the Association of Food and Drug Officials

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/24/2023
Location: Virtual
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA) Dialog Session
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Members of Pharmaceutical Research and Manufacturers of America (PhRMA)

Event Date: 10/26/2023
Location: Virtual
Subject: Centers of Excellence in Regulatory Science and Innovation (CERSI) Meeting
FDA Participant/Group: SHAAVHREE BUCKMAN GARNER;
Non FDA Participant/Group: Ehsan Samei, Rob Mentz, Susan Halabi (Duke University); Paul Watkins (University of North Carolina);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/25/2023
Location: Philadelphia, PA
Subject: International Society for Cell and Gene Therapy - American Society for Transplantation and Cellular Therapy Cell Therapy Training Course; Strategies for Regulatory Success: A Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the International Society for Cell and Gene Therapy - American Society for Transplantation and Cellular Therapy Cell Therapy Training Course

Event Date: 10/26/2023
Location: Arlington, VA
Subject: Critical Path Institute Scientific Breakthrough Summit; Exploring Gene and Cell-Based Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Critical Path Institute Scientific Breakthrough Summit

Event Date: 10/28/2023
Location: Washington, DC
Subject: The 2023 International Limb Girdle Muscular Dystrophy Conference; Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of The 2023 International Limb Girdle Muscular Dystrophy Conference

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 10/24/2023
Location: College Park, MD
Subject: Produce Meeting
FDA Participant/Group: KRISTIN ESCH; MICHAEL MAHOVIC; SAMIR ASSAR; MICHELLE SMITH; ANGELA FIELDS; DAVID INGRAM;
Non FDA Participant/Group: David Frye, Jeff Stoltzfuz, Jonas Yoder, Lloyd Schrock (Plain Farmers);

Event Date: 10/24/2023
Location: Virtual
Subject: Food Traceability Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives with United Natural Foods, Inc.

Event Date: 10/24/2023
Location: Virtual
Subject: Listening Session on FDA Nutrition Initiatives
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of American Indian and Alaska Native Tribes

Event Date: 10/26/2023
Location: College Park, MD
Subject: Joint Activities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of Marine and Fishery Quality Assurance Agency (MFQAA), Government of Indonesia

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/24/2023
Location: Virtual
Subject: Parents Against Vaping e-cigarettes (PAVe), Clear the Vapor Conference; Keynote Adress: FDA’s Actions to Address Youth E-Cigarette Use
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from Parents Against Vaping e-cigarettes (PAVe) and attendees

Event Date: 10/24/2023
Location: Omaha, NE
Subject: National Association of Attorneys General (NAAG) 2023 Tobacco Issues Seminar; Keynote Address: Tobacco Product Regulation - Looking Ahead at Opportunities and Challenges
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the National Association of Attorneys General

Event Date: 10/24/2023
Location: Omaha, NE
Subject: National Association of Attorneys General (NAAG) State Representatives Meeting on CTP Programmatic Updates and FDA/State Collaboration
FDA Participant/Group: N/A
Non FDA Participant/Group: Several state representatives from the National Association of Attorneys General

Event Date: 10/26/2023
Location: Washington, DC
Subject: Food and Drug Law Institute (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference; Keynote Address: FDA’s Comprehensive Approach to Tobacco Product Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Food and Drug Law Institute (FDLI) and other conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 10/24/2023
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: LINDSAY ALVAREZ; WILLIAM FLYNN; TRISTAN COLONIUS; TIMOTHY SCHELL;
Non FDA Participant/Group: Members of the Animal Health Institute (AHI)

Event Date: 10/24/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TIMOTHY SCHELL; SUSAN DEWITT; JEANETTE MURPHY; CHARLOTTE CONWAY; TRISTAN COLONIUS; SIOBHAN DELANCEY;
Non FDA Participant/Group: Dana Brooks, Patrick Tovey (Pet Food Industry (PFI));

Event Date: 10/25/2023
Location: Baltimore, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the Association of Food and Drug Officials (AFDO)

Event Date: 10/26/2023
Location: Virtual
Subject: Generic Animal Drug Alliance (GADA) / CVM Triannual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Generic Animal Drug Alliance (GADA)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event